 The Capitol Column |
FDA okays generic Singulair for asthma treatment
The Capitol Column The FDA announced Friday that it has approved the production of generic versions of Singulair, a drug used for the treatment of asthma and allergies. The patent on Singulair, or montelukast sodium, was held by Merck, and expired on Aug. 3, 2012. The … FDA Approves Generic Versions Of Singulair To Treat Asthma, Allergies FDA OKs generic Singulair Generic Singulair Approved |
View full post on asthma – Google News